Follow the Regis Healthcare Limited share price and the full management transaction log of the company, a listed equity based in Australia. Shares are quoted on the AU market, under the authority of ASX. Operating in the Health Care sector, Regis Healthcare Limited has recorded 5 insider filings. Market capitalisation: €1.8bn. The latest transaction was reported on 31 August 2026 (Purchase). Among the most active insiders: Carmel Anne Monaghan. Every trade is accessible without an account.
Analysts rate Regis Healthcare Limited Buy (bullish), based on 7 analysts. Average price target: A$7.44.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
5 of 5 declarations
Regis Healthcare Limited is an Australian company specializing in healthcare, providing aged care services. It is listed on the XASX market.